Avtor/Urednik		Šegota, Nikša
Naslov		Antibiotično zdravljenje zunajbolnišničnih pljučnic
Prevedeni naslov		The antibiotic treatment of community - acquired pneumonia
Tip		članek
Vir		In: Križman I, editor. Interna medicina 2005: novosti in aktualnosti. Zbornik predavanj 2. kongres Združenja internistov SZD; 2005 okt 21-22; Ljubljana. Ljubljana: Slovensko zdravniško društvo, Združenje internistov,
Leto izdaje		2005
Obseg		str. 319-23
Jezik		slo
Abstrakt		Pneumonia is an infection of the lung parenchyma. Community-acquired pneumonia (CAP) refers to pneumonia acquired outside of hospitals or extended-care facilities. It is a common disease associated with significant morbidity, mortality, and costs. Antimicrobial sensitivity, resistance, and pharmacoeconomics must be considered when selecting the antibiotic. The annual rate of CAP in Slovenia is approximately 15-20.000, one fifth of which need hospitalization. CAP is still a disease with high mortality: 4% in children under 5 years of age, 11% in patients above 60 years, 17% in patients above 75 years, and even 25% among patients requiring hospitalization. In Europe, the most likely CAP pathogens include Streptococcus pneumoniae (40-68%), Haemophillus influenzae (4-15%), Mycoplasma pneumoniae (2-18%), Chlamydia pneumoniae (4-15%), viruses (5-20%) and other bacteria. The Slovene Respiratory Society accepted the Slovene Guidelines for the management of community-acquired pneumonia in 2005. Similar epidemiology and bacterial susceptibility for antimicrobials in Slovenia and in Western European countries were the reason for Slovenia to adopt parts of British Thoracic and European Respiratory Society guidelines. The presentation brings and discusses the latest Slovene guidelines.
Deskriptorji		COMMUNITY-ACQUIRED INFECTIONS PNEUMONIA ANTIBIOTICS HOSPITALIZATION